Global AI Drug Repurposing Platform Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global AI Drug Repurposing Platform market size was valued at US$ 1338 million in 2025 and is forecast to a readjusted size of US$ 6336 million by 2032 with a CAGR of 23.9% during review period.
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
This report is a detailed and comprehensive analysis for global AI Drug Repurposing Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Drug Repurposing Platform market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Drug Repurposing Platform market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI Drug Repurposing Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Repurposing Platform, with revenue, gross margin, and global market share of AI Drug Repurposing Platform from 2021 to 2026.
Chapter 3, the AI Drug Repurposing Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Repurposing Platform market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Repurposing Platform.
Chapter 13, to describe AI Drug Repurposing Platform research findings and conclusion.
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
This report is a detailed and comprehensive analysis for global AI Drug Repurposing Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Drug Repurposing Platform market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Drug Repurposing Platform market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for AI Drug Repurposing Platform
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Drug Repurposing Platform market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Target and Mechanism Mining
- Drug?Disease Matching
- Indication Expansion
- Combination Therapy Prediction
- Evidence Ranking and Validation
- Safety and Translational Assessment
- Biomedical Knowledge Graphs
- Multi-Omics Data
- Clinical and Real-World Data
- Literature and Patent Data
- Chemical and Target Interaction Data
- Integrated Multimodal Data
- Knowledge Graph Reasoning
- Machine Learning Prediction
- Network Medicine Analysis
- Causal Inference Modeling
- Generative and Language Models
- Hybrid Expert-in-the-Loop Models
- SaaS Platform
- Private Deployment
- API and Data Service
- Project-Based Collaboration
- Platform with Wet-Lab Validation
- Rare Disease Repurposing
- Oncology Indication Expansion
- Infectious Disease Response
- CNS and Neurology Research
- Immunology and Inflammation Research
- Asset Rescue and Pipeline Optimization
- BenevolentAI
- Healx
- Insilico Medicine
- Recursion
- Lantern Pharma
- SOM Biotech
- Standigm
- Pharos iBio
- Aitia
- Causaly
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI Drug Repurposing Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Repurposing Platform, with revenue, gross margin, and global market share of AI Drug Repurposing Platform from 2021 to 2026.
Chapter 3, the AI Drug Repurposing Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Repurposing Platform market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Repurposing Platform.
Chapter 13, to describe AI Drug Repurposing Platform research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Repurposing Platform by Type
1.3.1 Overview: Global AI Drug Repurposing Platform Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Type in 2025
1.3.3 Target and Mechanism Mining
1.3.4 Drug?Disease Matching
1.3.5 Indication Expansion
1.3.6 Combination Therapy Prediction
1.3.7 Evidence Ranking and Validation
1.3.8 Safety and Translational Assessment
1.4 Classification of AI Drug Repurposing Platform by Data Foundation
1.4.1 Overview: Global AI Drug Repurposing Platform Market Size by Data Foundation: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Data Foundation in 2025
1.4.3 Biomedical Knowledge Graphs
1.4.4 Multi-Omics Data
1.4.5 Clinical and Real-World Data
1.4.6 Literature and Patent Data
1.4.7 Chemical and Target Interaction Data
1.4.8 Integrated Multimodal Data
1.5 Classification of AI Drug Repurposing Platform by Algorithmic Method
1.5.1 Overview: Global AI Drug Repurposing Platform Market Size by Algorithmic Method: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Algorithmic Method in 2025
1.5.3 Knowledge Graph Reasoning
1.5.4 Machine Learning Prediction
1.5.5 Network Medicine Analysis
1.5.6 Causal Inference Modeling
1.5.7 Generative and Language Models
1.5.8 Hybrid Expert-in-the-Loop Models
1.6 Classification of AI Drug Repurposing Platform by Delivery Mode
1.6.1 Overview: Global AI Drug Repurposing Platform Market Size by Delivery Mode: 2021 Versus 2025 Versus 2032
1.6.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Delivery Mode in 2025
1.6.3 SaaS Platform
1.6.4 Private Deployment
1.6.5 API and Data Service
1.6.6 Project-Based Collaboration
1.6.7 Platform with Wet-Lab Validation
1.7 Global AI Drug Repurposing Platform Market by Application
1.7.1 Overview: Global AI Drug Repurposing Platform Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Rare Disease Repurposing
1.7.3 Oncology Indication Expansion
1.7.4 Infectious Disease Response
1.7.5 CNS and Neurology Research
1.7.6 Immunology and Inflammation Research
1.7.7 Asset Rescue and Pipeline Optimization
1.8 Global AI Drug Repurposing Platform Market Size & Forecast
1.9 Global AI Drug Repurposing Platform Market Size and Forecast by Region
1.9.1 Global AI Drug Repurposing Platform Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global AI Drug Repurposing Platform Market Size by Region, (2021-2032)
1.9.3 North America AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.4 Europe AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.6 South America AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BenevolentAI
2.1.1 BenevolentAI Details
2.1.2 BenevolentAI Major Business
2.1.3 BenevolentAI AI Drug Repurposing Platform Product and Solutions
2.1.4 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BenevolentAI Recent Developments and Future Plans
2.2 Healx
2.2.1 Healx Details
2.2.2 Healx Major Business
2.2.3 Healx AI Drug Repurposing Platform Product and Solutions
2.2.4 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Healx Recent Developments and Future Plans
2.3 Insilico Medicine
2.3.1 Insilico Medicine Details
2.3.2 Insilico Medicine Major Business
2.3.3 Insilico Medicine AI Drug Repurposing Platform Product and Solutions
2.3.4 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Insilico Medicine Recent Developments and Future Plans
2.4 Recursion
2.4.1 Recursion Details
2.4.2 Recursion Major Business
2.4.3 Recursion AI Drug Repurposing Platform Product and Solutions
2.4.4 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Recursion Recent Developments and Future Plans
2.5 Lantern Pharma
2.5.1 Lantern Pharma Details
2.5.2 Lantern Pharma Major Business
2.5.3 Lantern Pharma AI Drug Repurposing Platform Product and Solutions
2.5.4 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Lantern Pharma Recent Developments and Future Plans
2.6 SOM Biotech
2.6.1 SOM Biotech Details
2.6.2 SOM Biotech Major Business
2.6.3 SOM Biotech AI Drug Repurposing Platform Product and Solutions
2.6.4 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 SOM Biotech Recent Developments and Future Plans
2.7 Standigm
2.7.1 Standigm Details
2.7.2 Standigm Major Business
2.7.3 Standigm AI Drug Repurposing Platform Product and Solutions
2.7.4 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Standigm Recent Developments and Future Plans
2.8 Pharos iBio
2.8.1 Pharos iBio Details
2.8.2 Pharos iBio Major Business
2.8.3 Pharos iBio AI Drug Repurposing Platform Product and Solutions
2.8.4 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Pharos iBio Recent Developments and Future Plans
2.9 Aitia
2.9.1 Aitia Details
2.9.2 Aitia Major Business
2.9.3 Aitia AI Drug Repurposing Platform Product and Solutions
2.9.4 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Aitia Recent Developments and Future Plans
2.10 Causaly
2.10.1 Causaly Details
2.10.2 Causaly Major Business
2.10.3 Causaly AI Drug Repurposing Platform Product and Solutions
2.10.4 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Causaly Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Repurposing Platform Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Drug Repurposing Platform by Company Revenue
3.2.2 Top 3 AI Drug Repurposing Platform Players Market Share in 2025
3.2.3 Top 6 AI Drug Repurposing Platform Players Market Share in 2025
3.3 AI Drug Repurposing Platform Market: Overall Company Footprint Analysis
3.3.1 AI Drug Repurposing Platform Market: Region Footprint
3.3.2 AI Drug Repurposing Platform Market: Company Product Type Footprint
3.3.3 AI Drug Repurposing Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Repurposing Platform Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Drug Repurposing Platform Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Drug Repurposing Platform Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
6.2 North America AI Drug Repurposing Platform Market Size by Application (2021-2032)
6.3 North America AI Drug Repurposing Platform Market Size by Country
6.3.1 North America AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
6.3.2 United States AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
6.3.3 Canada AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
7.2 Europe AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
7.3 Europe AI Drug Repurposing Platform Market Size by Country
7.3.1 Europe AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
7.3.2 Germany AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.3 France AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.5 Russia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.6 Italy AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Drug Repurposing Platform Market Size by Region
8.3.1 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2021-2032)
8.3.2 China AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.3 Japan AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.5 India AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.7 Australia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
9.2 South America AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
9.3 South America AI Drug Repurposing Platform Market Size by Country
9.3.1 South America AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Drug Repurposing Platform Market Size by Country
10.3.1 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10.3.4 UAE AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Drug Repurposing Platform Market Drivers
11.2 AI Drug Repurposing Platform Market Restraints
11.3 AI Drug Repurposing Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Repurposing Platform Industry Chain
12.2 AI Drug Repurposing Platform Upstream Analysis
12.3 AI Drug Repurposing Platform Midstream Analysis
12.4 AI Drug Repurposing Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Repurposing Platform by Type
1.3.1 Overview: Global AI Drug Repurposing Platform Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Type in 2025
1.3.3 Target and Mechanism Mining
1.3.4 Drug?Disease Matching
1.3.5 Indication Expansion
1.3.6 Combination Therapy Prediction
1.3.7 Evidence Ranking and Validation
1.3.8 Safety and Translational Assessment
1.4 Classification of AI Drug Repurposing Platform by Data Foundation
1.4.1 Overview: Global AI Drug Repurposing Platform Market Size by Data Foundation: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Data Foundation in 2025
1.4.3 Biomedical Knowledge Graphs
1.4.4 Multi-Omics Data
1.4.5 Clinical and Real-World Data
1.4.6 Literature and Patent Data
1.4.7 Chemical and Target Interaction Data
1.4.8 Integrated Multimodal Data
1.5 Classification of AI Drug Repurposing Platform by Algorithmic Method
1.5.1 Overview: Global AI Drug Repurposing Platform Market Size by Algorithmic Method: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Algorithmic Method in 2025
1.5.3 Knowledge Graph Reasoning
1.5.4 Machine Learning Prediction
1.5.5 Network Medicine Analysis
1.5.6 Causal Inference Modeling
1.5.7 Generative and Language Models
1.5.8 Hybrid Expert-in-the-Loop Models
1.6 Classification of AI Drug Repurposing Platform by Delivery Mode
1.6.1 Overview: Global AI Drug Repurposing Platform Market Size by Delivery Mode: 2021 Versus 2025 Versus 2032
1.6.2 Global AI Drug Repurposing Platform Consumption Value Market Share by Delivery Mode in 2025
1.6.3 SaaS Platform
1.6.4 Private Deployment
1.6.5 API and Data Service
1.6.6 Project-Based Collaboration
1.6.7 Platform with Wet-Lab Validation
1.7 Global AI Drug Repurposing Platform Market by Application
1.7.1 Overview: Global AI Drug Repurposing Platform Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Rare Disease Repurposing
1.7.3 Oncology Indication Expansion
1.7.4 Infectious Disease Response
1.7.5 CNS and Neurology Research
1.7.6 Immunology and Inflammation Research
1.7.7 Asset Rescue and Pipeline Optimization
1.8 Global AI Drug Repurposing Platform Market Size & Forecast
1.9 Global AI Drug Repurposing Platform Market Size and Forecast by Region
1.9.1 Global AI Drug Repurposing Platform Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global AI Drug Repurposing Platform Market Size by Region, (2021-2032)
1.9.3 North America AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.4 Europe AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.6 South America AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa AI Drug Repurposing Platform Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BenevolentAI
2.1.1 BenevolentAI Details
2.1.2 BenevolentAI Major Business
2.1.3 BenevolentAI AI Drug Repurposing Platform Product and Solutions
2.1.4 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BenevolentAI Recent Developments and Future Plans
2.2 Healx
2.2.1 Healx Details
2.2.2 Healx Major Business
2.2.3 Healx AI Drug Repurposing Platform Product and Solutions
2.2.4 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Healx Recent Developments and Future Plans
2.3 Insilico Medicine
2.3.1 Insilico Medicine Details
2.3.2 Insilico Medicine Major Business
2.3.3 Insilico Medicine AI Drug Repurposing Platform Product and Solutions
2.3.4 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Insilico Medicine Recent Developments and Future Plans
2.4 Recursion
2.4.1 Recursion Details
2.4.2 Recursion Major Business
2.4.3 Recursion AI Drug Repurposing Platform Product and Solutions
2.4.4 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Recursion Recent Developments and Future Plans
2.5 Lantern Pharma
2.5.1 Lantern Pharma Details
2.5.2 Lantern Pharma Major Business
2.5.3 Lantern Pharma AI Drug Repurposing Platform Product and Solutions
2.5.4 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Lantern Pharma Recent Developments and Future Plans
2.6 SOM Biotech
2.6.1 SOM Biotech Details
2.6.2 SOM Biotech Major Business
2.6.3 SOM Biotech AI Drug Repurposing Platform Product and Solutions
2.6.4 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 SOM Biotech Recent Developments and Future Plans
2.7 Standigm
2.7.1 Standigm Details
2.7.2 Standigm Major Business
2.7.3 Standigm AI Drug Repurposing Platform Product and Solutions
2.7.4 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Standigm Recent Developments and Future Plans
2.8 Pharos iBio
2.8.1 Pharos iBio Details
2.8.2 Pharos iBio Major Business
2.8.3 Pharos iBio AI Drug Repurposing Platform Product and Solutions
2.8.4 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Pharos iBio Recent Developments and Future Plans
2.9 Aitia
2.9.1 Aitia Details
2.9.2 Aitia Major Business
2.9.3 Aitia AI Drug Repurposing Platform Product and Solutions
2.9.4 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Aitia Recent Developments and Future Plans
2.10 Causaly
2.10.1 Causaly Details
2.10.2 Causaly Major Business
2.10.3 Causaly AI Drug Repurposing Platform Product and Solutions
2.10.4 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Causaly Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Repurposing Platform Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Drug Repurposing Platform by Company Revenue
3.2.2 Top 3 AI Drug Repurposing Platform Players Market Share in 2025
3.2.3 Top 6 AI Drug Repurposing Platform Players Market Share in 2025
3.3 AI Drug Repurposing Platform Market: Overall Company Footprint Analysis
3.3.1 AI Drug Repurposing Platform Market: Region Footprint
3.3.2 AI Drug Repurposing Platform Market: Company Product Type Footprint
3.3.3 AI Drug Repurposing Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Repurposing Platform Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Drug Repurposing Platform Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Drug Repurposing Platform Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
6.2 North America AI Drug Repurposing Platform Market Size by Application (2021-2032)
6.3 North America AI Drug Repurposing Platform Market Size by Country
6.3.1 North America AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
6.3.2 United States AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
6.3.3 Canada AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
7.2 Europe AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
7.3 Europe AI Drug Repurposing Platform Market Size by Country
7.3.1 Europe AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
7.3.2 Germany AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.3 France AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.5 Russia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
7.3.6 Italy AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Drug Repurposing Platform Market Size by Region
8.3.1 Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2021-2032)
8.3.2 China AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.3 Japan AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.5 India AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
8.3.7 Australia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
9.2 South America AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
9.3 South America AI Drug Repurposing Platform Market Size by Country
9.3.1 South America AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Drug Repurposing Platform Market Size by Country
10.3.1 Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
10.3.4 UAE AI Drug Repurposing Platform Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Drug Repurposing Platform Market Drivers
11.2 AI Drug Repurposing Platform Market Restraints
11.3 AI Drug Repurposing Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Repurposing Platform Industry Chain
12.2 AI Drug Repurposing Platform Upstream Analysis
12.3 AI Drug Repurposing Platform Midstream Analysis
12.4 AI Drug Repurposing Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Drug Repurposing Platform Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Drug Repurposing Platform Consumption Value by Data Foundation, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Drug Repurposing Platform Consumption Value by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Drug Repurposing Platform Consumption Value by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Drug Repurposing Platform Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global AI Drug Repurposing Platform Consumption Value by Region (2027-2032) & (USD Million)
Table 8. BenevolentAI Company Information, Head Office, and Major Competitors
Table 9. BenevolentAI Major Business
Table 10. BenevolentAI AI Drug Repurposing Platform Product and Solutions
Table 11. BenevolentAI AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. BenevolentAI Recent Developments and Future Plans
Table 13. Healx Company Information, Head Office, and Major Competitors
Table 14. Healx Major Business
Table 15. Healx AI Drug Repurposing Platform Product and Solutions
Table 16. Healx AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Healx Recent Developments and Future Plans
Table 18. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 19. Insilico Medicine Major Business
Table 20. Insilico Medicine AI Drug Repurposing Platform Product and Solutions
Table 21. Insilico Medicine AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Recursion Company Information, Head Office, and Major Competitors
Table 23. Recursion Major Business
Table 24. Recursion AI Drug Repurposing Platform Product and Solutions
Table 25. Recursion AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Recursion Recent Developments and Future Plans
Table 27. Lantern Pharma Company Information, Head Office, and Major Competitors
Table 28. Lantern Pharma Major Business
Table 29. Lantern Pharma AI Drug Repurposing Platform Product and Solutions
Table 30. Lantern Pharma AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Lantern Pharma Recent Developments and Future Plans
Table 32. SOM Biotech Company Information, Head Office, and Major Competitors
Table 33. SOM Biotech Major Business
Table 34. SOM Biotech AI Drug Repurposing Platform Product and Solutions
Table 35. SOM Biotech AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. SOM Biotech Recent Developments and Future Plans
Table 37. Standigm Company Information, Head Office, and Major Competitors
Table 38. Standigm Major Business
Table 39. Standigm AI Drug Repurposing Platform Product and Solutions
Table 40. Standigm AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Standigm Recent Developments and Future Plans
Table 42. Pharos iBio Company Information, Head Office, and Major Competitors
Table 43. Pharos iBio Major Business
Table 44. Pharos iBio AI Drug Repurposing Platform Product and Solutions
Table 45. Pharos iBio AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Pharos iBio Recent Developments and Future Plans
Table 47. Aitia Company Information, Head Office, and Major Competitors
Table 48. Aitia Major Business
Table 49. Aitia AI Drug Repurposing Platform Product and Solutions
Table 50. Aitia AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Aitia Recent Developments and Future Plans
Table 52. Causaly Company Information, Head Office, and Major Competitors
Table 53. Causaly Major Business
Table 54. Causaly AI Drug Repurposing Platform Product and Solutions
Table 55. Causaly AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Causaly Recent Developments and Future Plans
Table 57. Global AI Drug Repurposing Platform Revenue (USD Million) by Players (2021-2026)
Table 58. Global AI Drug Repurposing Platform Revenue Share by Players (2021-2026)
Table 59. Breakdown of AI Drug Repurposing Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 60. Market Position of Players in AI Drug Repurposing Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 61. Head Office of Key AI Drug Repurposing Platform Players
Table 62. AI Drug Repurposing Platform Market: Company Product Type Footprint
Table 63. AI Drug Repurposing Platform Market: Company Product Application Footprint
Table 64. AI Drug Repurposing Platform New Market Entrants and Barriers to Market Entry
Table 65. AI Drug Repurposing Platform Mergers, Acquisition, Agreements, and Collaborations
Table 66. Global AI Drug Repurposing Platform Consumption Value (USD Million) by Type (2021-2026)
Table 67. Global AI Drug Repurposing Platform Consumption Value Share by Type (2021-2026)
Table 68. Global AI Drug Repurposing Platform Consumption Value Forecast by Type (2027-2032)
Table 69. Global AI Drug Repurposing Platform Consumption Value by Application (2021-2026)
Table 70. Global AI Drug Repurposing Platform Consumption Value Forecast by Application (2027-2032)
Table 71. North America AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 72. North America AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 73. North America AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 74. North America AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 75. North America AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 76. North America AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 77. Europe AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 78. Europe AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 79. Europe AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 80. Europe AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 81. Europe AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Europe AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 84. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 85. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 86. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 87. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2027-2032) & (USD Million)
Table 89. South America AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 90. South America AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 91. South America AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 92. South America AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 93. South America AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 94. South America AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Global Key Players of AI Drug Repurposing Platform Upstream (Raw Materials)
Table 102. Global AI Drug Repurposing Platform Typical Customers
Table 1. Global AI Drug Repurposing Platform Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Drug Repurposing Platform Consumption Value by Data Foundation, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Drug Repurposing Platform Consumption Value by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Drug Repurposing Platform Consumption Value by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Drug Repurposing Platform Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global AI Drug Repurposing Platform Consumption Value by Region (2027-2032) & (USD Million)
Table 8. BenevolentAI Company Information, Head Office, and Major Competitors
Table 9. BenevolentAI Major Business
Table 10. BenevolentAI AI Drug Repurposing Platform Product and Solutions
Table 11. BenevolentAI AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. BenevolentAI Recent Developments and Future Plans
Table 13. Healx Company Information, Head Office, and Major Competitors
Table 14. Healx Major Business
Table 15. Healx AI Drug Repurposing Platform Product and Solutions
Table 16. Healx AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Healx Recent Developments and Future Plans
Table 18. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 19. Insilico Medicine Major Business
Table 20. Insilico Medicine AI Drug Repurposing Platform Product and Solutions
Table 21. Insilico Medicine AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Recursion Company Information, Head Office, and Major Competitors
Table 23. Recursion Major Business
Table 24. Recursion AI Drug Repurposing Platform Product and Solutions
Table 25. Recursion AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Recursion Recent Developments and Future Plans
Table 27. Lantern Pharma Company Information, Head Office, and Major Competitors
Table 28. Lantern Pharma Major Business
Table 29. Lantern Pharma AI Drug Repurposing Platform Product and Solutions
Table 30. Lantern Pharma AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Lantern Pharma Recent Developments and Future Plans
Table 32. SOM Biotech Company Information, Head Office, and Major Competitors
Table 33. SOM Biotech Major Business
Table 34. SOM Biotech AI Drug Repurposing Platform Product and Solutions
Table 35. SOM Biotech AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. SOM Biotech Recent Developments and Future Plans
Table 37. Standigm Company Information, Head Office, and Major Competitors
Table 38. Standigm Major Business
Table 39. Standigm AI Drug Repurposing Platform Product and Solutions
Table 40. Standigm AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Standigm Recent Developments and Future Plans
Table 42. Pharos iBio Company Information, Head Office, and Major Competitors
Table 43. Pharos iBio Major Business
Table 44. Pharos iBio AI Drug Repurposing Platform Product and Solutions
Table 45. Pharos iBio AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Pharos iBio Recent Developments and Future Plans
Table 47. Aitia Company Information, Head Office, and Major Competitors
Table 48. Aitia Major Business
Table 49. Aitia AI Drug Repurposing Platform Product and Solutions
Table 50. Aitia AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Aitia Recent Developments and Future Plans
Table 52. Causaly Company Information, Head Office, and Major Competitors
Table 53. Causaly Major Business
Table 54. Causaly AI Drug Repurposing Platform Product and Solutions
Table 55. Causaly AI Drug Repurposing Platform Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Causaly Recent Developments and Future Plans
Table 57. Global AI Drug Repurposing Platform Revenue (USD Million) by Players (2021-2026)
Table 58. Global AI Drug Repurposing Platform Revenue Share by Players (2021-2026)
Table 59. Breakdown of AI Drug Repurposing Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 60. Market Position of Players in AI Drug Repurposing Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 61. Head Office of Key AI Drug Repurposing Platform Players
Table 62. AI Drug Repurposing Platform Market: Company Product Type Footprint
Table 63. AI Drug Repurposing Platform Market: Company Product Application Footprint
Table 64. AI Drug Repurposing Platform New Market Entrants and Barriers to Market Entry
Table 65. AI Drug Repurposing Platform Mergers, Acquisition, Agreements, and Collaborations
Table 66. Global AI Drug Repurposing Platform Consumption Value (USD Million) by Type (2021-2026)
Table 67. Global AI Drug Repurposing Platform Consumption Value Share by Type (2021-2026)
Table 68. Global AI Drug Repurposing Platform Consumption Value Forecast by Type (2027-2032)
Table 69. Global AI Drug Repurposing Platform Consumption Value by Application (2021-2026)
Table 70. Global AI Drug Repurposing Platform Consumption Value Forecast by Application (2027-2032)
Table 71. North America AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 72. North America AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 73. North America AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 74. North America AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 75. North America AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 76. North America AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 77. Europe AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 78. Europe AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 79. Europe AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 80. Europe AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 81. Europe AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Europe AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 84. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 85. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 86. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 87. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific AI Drug Repurposing Platform Consumption Value by Region (2027-2032) & (USD Million)
Table 89. South America AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 90. South America AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 91. South America AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 92. South America AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 93. South America AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 94. South America AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa AI Drug Repurposing Platform Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Global Key Players of AI Drug Repurposing Platform Upstream (Raw Materials)
Table 102. Global AI Drug Repurposing Platform Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Repurposing Platform Picture
Figure 2. Global AI Drug Repurposing Platform Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Drug Repurposing Platform Consumption Value Market Share by Type in 2025
Figure 4. Target and Mechanism Mining
Figure 5. Drug?Disease Matching
Figure 6. Indication Expansion
Figure 7. Combination Therapy Prediction
Figure 8. Evidence Ranking and Validation
Figure 9. Safety and Translational Assessment
Figure 10. Global AI Drug Repurposing Platform Consumption Value by Data Foundation, (USD Million), 2021 & 2025 & 2032
Figure 11. Global AI Drug Repurposing Platform Consumption Value Market Share by Data Foundation in 2025
Figure 12. Biomedical Knowledge Graphs
Figure 13. Multi-Omics Data
Figure 14. Clinical and Real-World Data
Figure 15. Literature and Patent Data
Figure 16. Chemical and Target Interaction Data
Figure 17. Integrated Multimodal Data
Figure 18. Global AI Drug Repurposing Platform Consumption Value by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Figure 19. Global AI Drug Repurposing Platform Consumption Value Market Share by Algorithmic Method in 2025
Figure 20. Knowledge Graph Reasoning
Figure 21. Machine Learning Prediction
Figure 22. Network Medicine Analysis
Figure 23. Causal Inference Modeling
Figure 24. Generative and Language Models
Figure 25. Hybrid Expert-in-the-Loop Models
Figure 26. Global AI Drug Repurposing Platform Consumption Value by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Figure 27. Global AI Drug Repurposing Platform Consumption Value Market Share by Delivery Mode in 2025
Figure 28. SaaS Platform
Figure 29. Private Deployment
Figure 30. API and Data Service
Figure 31. Project-Based Collaboration
Figure 32. Platform with Wet-Lab Validation
Figure 33. Global AI Drug Repurposing Platform Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. AI Drug Repurposing Platform Consumption Value Market Share by Application in 2025
Figure 35. Rare Disease Repurposing Picture
Figure 36. Oncology Indication Expansion Picture
Figure 37. Infectious Disease Response Picture
Figure 38. CNS and Neurology Research Picture
Figure 39. Immunology and Inflammation Research Picture
Figure 40. Asset Rescue and Pipeline Optimization Picture
Figure 41. Global AI Drug Repurposing Platform Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 42. Global AI Drug Repurposing Platform Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 43. Global Market AI Drug Repurposing Platform Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 44. Global AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 45. Global AI Drug Repurposing Platform Consumption Value Market Share by Region in 2025
Figure 46. North America AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 49. South America AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 50. Middle East & Africa AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 51. Company Three Recent Developments and Future Plans
Figure 52. Global AI Drug Repurposing Platform Revenue Share by Players in 2025
Figure 53. AI Drug Repurposing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 54. Market Share of AI Drug Repurposing Platform by Player Revenue in 2025
Figure 55. Top 3 AI Drug Repurposing Platform Players Market Share in 2025
Figure 56. Top 6 AI Drug Repurposing Platform Players Market Share in 2025
Figure 57. Global AI Drug Repurposing Platform Consumption Value Share by Type (2021-2026)
Figure 58. Global AI Drug Repurposing Platform Market Share Forecast by Type (2027-2032)
Figure 59. Global AI Drug Repurposing Platform Consumption Value Share by Application (2021-2026)
Figure 60. Global AI Drug Repurposing Platform Market Share Forecast by Application (2027-2032)
Figure 61. North America AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 62. North America AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 63. North America AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 64. United States AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 65. Canada AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 66. Mexico AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 67. Europe AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 68. Europe AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 69. Europe AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 70. Germany AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 71. France AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 72. United Kingdom AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 73. Russia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 74. Italy AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 75. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 76. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 77. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 78. China AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 79. Japan AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 80. South Korea AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 81. India AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 82. Southeast Asia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 83. Australia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 84. South America AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 85. South America AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 86. South America AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 87. Brazil AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 88. Argentina AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 89. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 90. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 91. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 92. Turkey AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 93. Saudi Arabia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 94. UAE AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 95. AI Drug Repurposing Platform Market Drivers
Figure 96. AI Drug Repurposing Platform Market Restraints
Figure 97. AI Drug Repurposing Platform Market Trends
Figure 98. Porters Five Forces Analysis
Figure 99. AI Drug Repurposing Platform Industrial Chain
Figure 100. Methodology
Figure 101. Research Process and Data Source
Figure 1. AI Drug Repurposing Platform Picture
Figure 2. Global AI Drug Repurposing Platform Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Drug Repurposing Platform Consumption Value Market Share by Type in 2025
Figure 4. Target and Mechanism Mining
Figure 5. Drug?Disease Matching
Figure 6. Indication Expansion
Figure 7. Combination Therapy Prediction
Figure 8. Evidence Ranking and Validation
Figure 9. Safety and Translational Assessment
Figure 10. Global AI Drug Repurposing Platform Consumption Value by Data Foundation, (USD Million), 2021 & 2025 & 2032
Figure 11. Global AI Drug Repurposing Platform Consumption Value Market Share by Data Foundation in 2025
Figure 12. Biomedical Knowledge Graphs
Figure 13. Multi-Omics Data
Figure 14. Clinical and Real-World Data
Figure 15. Literature and Patent Data
Figure 16. Chemical and Target Interaction Data
Figure 17. Integrated Multimodal Data
Figure 18. Global AI Drug Repurposing Platform Consumption Value by Algorithmic Method, (USD Million), 2021 & 2025 & 2032
Figure 19. Global AI Drug Repurposing Platform Consumption Value Market Share by Algorithmic Method in 2025
Figure 20. Knowledge Graph Reasoning
Figure 21. Machine Learning Prediction
Figure 22. Network Medicine Analysis
Figure 23. Causal Inference Modeling
Figure 24. Generative and Language Models
Figure 25. Hybrid Expert-in-the-Loop Models
Figure 26. Global AI Drug Repurposing Platform Consumption Value by Delivery Mode, (USD Million), 2021 & 2025 & 2032
Figure 27. Global AI Drug Repurposing Platform Consumption Value Market Share by Delivery Mode in 2025
Figure 28. SaaS Platform
Figure 29. Private Deployment
Figure 30. API and Data Service
Figure 31. Project-Based Collaboration
Figure 32. Platform with Wet-Lab Validation
Figure 33. Global AI Drug Repurposing Platform Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. AI Drug Repurposing Platform Consumption Value Market Share by Application in 2025
Figure 35. Rare Disease Repurposing Picture
Figure 36. Oncology Indication Expansion Picture
Figure 37. Infectious Disease Response Picture
Figure 38. CNS and Neurology Research Picture
Figure 39. Immunology and Inflammation Research Picture
Figure 40. Asset Rescue and Pipeline Optimization Picture
Figure 41. Global AI Drug Repurposing Platform Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 42. Global AI Drug Repurposing Platform Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 43. Global Market AI Drug Repurposing Platform Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 44. Global AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 45. Global AI Drug Repurposing Platform Consumption Value Market Share by Region in 2025
Figure 46. North America AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 49. South America AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 50. Middle East & Africa AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 51. Company Three Recent Developments and Future Plans
Figure 52. Global AI Drug Repurposing Platform Revenue Share by Players in 2025
Figure 53. AI Drug Repurposing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 54. Market Share of AI Drug Repurposing Platform by Player Revenue in 2025
Figure 55. Top 3 AI Drug Repurposing Platform Players Market Share in 2025
Figure 56. Top 6 AI Drug Repurposing Platform Players Market Share in 2025
Figure 57. Global AI Drug Repurposing Platform Consumption Value Share by Type (2021-2026)
Figure 58. Global AI Drug Repurposing Platform Market Share Forecast by Type (2027-2032)
Figure 59. Global AI Drug Repurposing Platform Consumption Value Share by Application (2021-2026)
Figure 60. Global AI Drug Repurposing Platform Market Share Forecast by Application (2027-2032)
Figure 61. North America AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 62. North America AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 63. North America AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 64. United States AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 65. Canada AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 66. Mexico AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 67. Europe AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 68. Europe AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 69. Europe AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 70. Germany AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 71. France AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 72. United Kingdom AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 73. Russia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 74. Italy AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 75. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 76. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 77. Asia-Pacific AI Drug Repurposing Platform Consumption Value Market Share by Region (2021-2032)
Figure 78. China AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 79. Japan AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 80. South Korea AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 81. India AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 82. Southeast Asia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 83. Australia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 84. South America AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 85. South America AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 86. South America AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 87. Brazil AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 88. Argentina AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 89. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Type (2021-2032)
Figure 90. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Application (2021-2032)
Figure 91. Middle East & Africa AI Drug Repurposing Platform Consumption Value Market Share by Country (2021-2032)
Figure 92. Turkey AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 93. Saudi Arabia AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 94. UAE AI Drug Repurposing Platform Consumption Value (2021-2032) & (USD Million)
Figure 95. AI Drug Repurposing Platform Market Drivers
Figure 96. AI Drug Repurposing Platform Market Restraints
Figure 97. AI Drug Repurposing Platform Market Trends
Figure 98. Porters Five Forces Analysis
Figure 99. AI Drug Repurposing Platform Industrial Chain
Figure 100. Methodology
Figure 101. Research Process and Data Source
